Insulet
PODD
467 hedge funds and large institutions have $16.3B invested in Insulet in 2022 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 167 increasing their positions, 161 reducing their positions, and 36 closing their positions.
56% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 36
4% more funds holding
Funds holding: 449 → 467 (+18)
5% more capital invested
Capital invested by funds: $15.6B → $16.3B (+$725M)
4% more repeat investments, than reductions
Existing positions increased: 167 | Existing positions reduced: 161
0.72% less ownership
Funds ownership: 103.31% → 102.59% (-0.72%)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
40% less call options, than puts
Call options by funds: $36.6M | Put options by funds: $61.1M
Top Buyers
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$64.9M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$34.8M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$27M |
| 4 |
DCP
D1 Capital Partners
New York
|
+$23.1M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$20.3M |
Top Sellers
PODD Hedge Fund Activity: Q3 2022 in Review
467 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q3 2022, worth a combined $16.3B — up 4.6% from $15.6B a quarter earlier.
Buyers outnumbered sellers: 56 funds opened new PODD positions and 36 closed out — a net gain of 20 holders — while 167 added to existing stakes and 161 trimmed.
The largest buyer was Lord, Abbett & Co, adding an estimated $64.9M. The largest seller was Marshall Wace, cutting an estimated $108M.
- 467 institutional investors held Insulet (PODD) as of Q3 2022, up from 449 in Q2 2022.
- Funds reported $16.3B of Insulet stock for Q3 2022, up 4.6% quarter-over-quarter.
- 56 funds opened new Insulet positions in Q3 2022 and 36 closed out, a net change of +20 holders.
- The largest Insulet buyer in Q3 2022 was Lord, Abbett & Co, an estimated $64.9M added.
- The largest Insulet seller in Q3 2022 was Marshall Wace, an estimated $108M sold.
Based on aggregated 13F filings for Q3 2022.